Document |
Document Title |
WO/2020/247335A1 |
A composition contains an alpha-beta unsaturated ester, a silyl hydride, and a Bridged Frustrated Lewis Pair.
|
WO/2020/247332A1 |
A composition contains a mixture of silyl hydride, a silanols and/or silyl ether, a Lewis acid catalyst and an amine having the following formula: R1R2R3N; where the nitrogen is not a member of an N=C-N linkage and each of R1, R2, and R3...
|
WO/2020/247337A1 |
A composition contains a mixture of silyl hydride, an epoxide, a Lewis acid catalyst and an amine having the following formula: R1 R2 R3 N; where the nitrogen (N) is not a member of a N=C-N linkage and wherein each of R1, R2, and R3 is i...
|
WO/2020/247338A1 |
A composition contains a mixture of silyl hydride, epoxide and a Bridged Frustrated Lewis Pair.
|
WO/2020/247330A1 |
A composition contains a mixture of silyl hydride, a siloxane and a Bridged Frustrated Lewis Pair and can be thermally triggered to cure.
|
WO/2020/247662A1 |
Disclosed are diboronic acid compounds and diboronic acid compound-based sensors for glucose detection, as well as methods for glucose testing in a sample. The diboronic acid compounds allow for selective detection of glucose in the pres...
|
WO/2020/247334A1 |
A composition contains a mixture of silyl hydride, a silanol and/or a silyl ether, and a Bridged Frustrated Lewis Pair.
|
WO/2020/244988A1 |
The present invention is in the field of processes for preparing inorganic metal- or semimetal- containing films. The process comprising (a) depositing a metal- or semimetal-containing compound from the gaseous state onto a solid substra...
|
WO/2020/237806A1 |
The present invention relates to the field of organic synthesis. Provided is a preparation method for 4-fluorine-3-methoxyl-5-methylaniline hydrochloride. A synthetic route of the preparation method for 4-fluorine-3-methoxyl-5-methylanil...
|
WO/2020/238375A1 |
Disclosed is a fluorescent compound having affinity with an Aβ oligomer, and a preparation method and the use thereof. The fluorescent compound obtained in the present invention has maximum excitation and fluorescence emission spectrum ...
|
WO/2020/242948A1 |
The application is drawn to 18F-radiolabeled residualizing agents and biomolecules and methods for radiolabeling biomolecules with radioactive fluorine atoms. The biomolecules have an affinity for particular types of cells and may specif...
|
WO/2020/241498A1 |
Provided is a luminescent europium complex that has high ability to absorb long-wavelength ultraviolet light, and that is highly soluble. This europium complex is represented by formula (1). (R1, R2, and R3 each independently represent a...
|
WO/2020/242165A1 |
The present invention relates to a novel organic compound and an organic light-emitting device comprising same and, more specifically, to an organic compound having excellent longevity, efficiency, electrochemical stability, and thermal ...
|
WO/2020/236253A1 |
Disclosed herein are compounds of Formula (I) or (II). The compounds include an agent (e.g., pharmaceutical agent, cosmetic agent, or nutraceutical agent) through a linker that includes a boronic ester moiety in the backbone of the linke...
|
WO/2020/232470A1 |
The present invention describes novel compounds, or their pharmaceutically acceptable salts, pharmaceutical compositions containing them, and their medical uses. The compounds of the invention have activity as Janus kinase (JAK) inhibito...
|
WO/2020/230820A1 |
The purpose of the present invention is to produce a high-quality metal-organic structure in a short period of time. The method for producing a metal-organic structure according to the present invention comprises applying centrifugal for...
|
WO/2020/229595A1 |
The present invention relates to compounds of formula (I) and compositions containing said compounds acting as PARP (Poly (ADP- ribose) polymerase) inhibitors. Moreover, the present invention provides processes for the preparation of the...
|
WO/2020/230756A1 |
The present invention addresses the problem of providing a metal-organic structural body capable of adsorbing gases such as carbon dioxide and hydrogen molecules at a practical level for use. This metal-organic structural body is used fo...
|
WO/2020/225273A1 |
Disclosed herein are new C-mannoside compounds and compositions and their application as pharmaceuticals for the treatment of human disease. Methods of inhibition of FimH activity in human subjects are also provided for the treatment dis...
|
WO/2020/221744A1 |
The present invention relates to a method for radioiodination or radioastatination of a biomolecule such as proteins and antibodies by reacting a biomolecule carrying a hetero(aryl) boronic acid group with a radioiodide or astatide salt,...
|
WO/2020/219049A1 |
The present disclosure provides indolinium borate activators comprising cations having linear alkyl groups, catalyst systems comprising, and processes for polymerizing olefins using such activators. Specifically, the present disclosure p...
|
WO/2020/218079A1 |
According to the present invention, options for materials for organic devices such as materials for organic EL elements are increased by addition of a cycloalkane, by condensation, to a polycyclic aromatic compound in which a plurality o...
|
WO/2020/218558A1 |
Provided is a compound having at least one structure represented by formula (i), as a material used in an organic EL element or other organic device. In formula (1): rings A, B, and C each independently represent an aromatic ring structu...
|
WO/2020/219718A1 |
Disclosed herein are compounds and methods for treating cancer and neurodegenerative diseases. In some examples, the compounds increase autophagy.
|
WO/2020/219719A1 |
Provided herein are antibodies that bind to neuraminidase (NA) of different strains of influenza B virus, host cells for producing such antibodies, and kits comprising such antibodies. Also provided herein are compositions comprising ant...
|
WO/2020/217229A1 |
Specific polycyclic compounds, a material for an organic electroluminescence device comprising said specific polycyclic compound, an organic electroluminescence device comprising said specific polycyclic compound, an electronic equipment...
|
WO/2020/219050A1 |
The present disclosure provides benzimidazolium borate activators comprising benzimidazobum cations having linear alkyl groups, catalyst systems comprising, and processes for polymerizing olefins using such activators. Specifically, the ...
|
WO/2020/218451A1 |
Disclosed is a rare earth complex having a rare earth ion and a phosphine oxide ligand that is coordinated with the rare earth ion and that is represented by formula (I) (where R1, R2, R3, R4, R5 and R6 are each independently an optional...
|
WO/2020/213359A1 |
In a method for producing an indium carboxylate according to the present invention, a product is obtained by reacting a hydroxyl group-containing indium carboxylate represented by formula (1): In(RCOO)3-x(OH)x (in the formula, R is a lin...
|
WO/2020/210649A1 |
The present disclosure provides certain bicyclic heteroaryl compounds that inhibit ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1) enzymatic activity and are therefore useful for the treatment of diseases and conditions modula...
|
WO/2020/210761A1 |
The present disclosure relates to novel photoluminescent complexes comprising a BODIPY moiety covalently bonded to a blue light absorbing moiety, a color conversion film comprising the photoluminescent complex, and a back-light unit usin...
|
WO/2020/210485A1 |
Disclosed are processes for preparing α-carboxamide pyrrolidine derivatives, in particular (2S,5R)-5-(4-((2-fluorobenzyl)oxy)phenyl)pyrrolidine-2-carbo
xamide, and intermediates for use in said processes along with processes for prepari...
|
WO/2020/208307A1 |
The present invention relates to crystalline form 1 of 6-(3, 5-dimethylisoxazol-4-yl)-7- methoxy-3 -methyl- 1 -(pyridin-2-ylmethyl)quinolin-2( 1 H)-one (I) and to a method of manufacture thereof Compound (I) is a BET inhibitor useful in ...
|
WO/2020/208051A1 |
The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices, and to electronic devices which comprise these compounds.
|
WO/2020/203783A1 |
The present invention provides: a raw material which is for forming a thin film and contains a scandium compound represented by general formula (1) below; a method for producing a thin film using the raw material for forming a thin film;...
|
WO/2020/200957A1 |
The present invention relates to a bicyclic triol borate of general formula (I) and to the use thereof in an electrolyte composition. The present invention relates in particular to the use of a bicyclic triol borate in an electrolyte com...
|
WO/2020/205932A1 |
Disclosed herein are crystalline forms of ((2-Ethylbutanoyl)oxy)methyl (R)-2-hydroxy-3-propionamido-3,4-dihydro-2H-benzo[e][1,2]oxa
borinine-8-carboxylate. Also disclosed herein are methods of treating a bacterial with a crystalline form...
|
WO/2020/200884A1 |
The invention relates to an organic molecule, in particular for the use in optoelectronic devices. According to the invention, the organic molecule has: - one first chemical moiety has a structure of Formula I, and - at least one second ...
|
WO/2020/193794A1 |
The invention relates to metal complexes of formula (I): [M(L1)x(L2)y(hydra)z]n formula (I) wherein: M = metal atom of an atomic number selected from the ranges a) to c): a) 12, 21 to 34, with the exception of 30, b) 39 to 52, with the e...
|
WO/2020/192271A1 |
Disclosed is a fluorescent compound as represented by general formula I, or salts, enantiomers, diastereomers, tautomers, solvates or polymorphs thereof, having the structure (I); wherein m and n are each independently an integer between...
|
WO/2020/187865A1 |
The invention relates to compounds which are suitable for use in electronic devices, and to electronic devices, in particular organic electroluminescent devices, containing said compounds.
|
WO/2020/189117A1 |
A π-conjugated compound according to the present invention has a structure represented by general formula (1), while having a HOMO level of -5.3 eV or more. (In the formula, M represents CX1 or a nitrogen atom; each of X1-X6 represents ...
|
WO/2020/184834A1 |
The present specification relates to a compound represented by chemical formula 1 and an organic light emitting device comprising same.
|
WO/2020/184369A1 |
The purpose of the present invention is to provide a red-light-emitting material having high light emission efficiency and excellent color purity and a red-light-emitting element. This invention is a pyrromethene metal complex represente...
|
WO/2020/184690A1 |
This lithium borate compound is represented by formula (I). In formula (I), R1, R2, and R3 each independently represent an optionally substituted hydrocarbon group having 1-20 carbon atoms. R10 represents a fluorine atom, a hydrocarbon o...
|
WO/2020/180390A1 |
Borylated Amino Acid ("BAA") compositions and methods of making BAAs are disclosed herein. Consequently, the BAAs can be administered to patients as a Neutron Capture Agent and provide a method of treating cancer, immunological disorders...
|
WO/2020/180272A1 |
This invention concerns the potable boron solution applied particularly in textile, polymer chemistry, metal, paper, healthcare and cosmetic industries. By this product, it is intended to extract boric oxide (10) by reacting boric acid w...
|
WO/2020/175902A1 |
The present specification relates to a compound represented by chemical formula 1, a color conversion film comprising same, a back-light unit, and a display device.
|
WO/2020/175901A1 |
The present specification relates to a compound represented by chemical formula 1, a color conversion film comprising same, a backlight unit, and a display device.
|
WO/2020/174346A1 |
The present invention relates to a novel tetraarylborate compound, a catalyst composition comprising same, and a method for preparing ethylene homopolymers or copolymers of ethylene and α-olefins by using same. In detail, the tetraarylb...
|